Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis.
<h4>Background</h4>Treatment and prevention of thrombotic complications is frequently required in patients with cirrhosis. However anticoagulant therapy is often withheld from these patients, because of the perceived bleeding diathesis. As a result of the limited clinical experience, the...
Saved in:
Main Authors: | Wilma Potze, Freeha Arshad, Jelle Adelmeijer, Hans Blokzijl, Arie P van den Berg, Joost C M Meijers, Robert J Porte, Ton Lisman |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/ab5c946e84b14f6f9c4891e1f2c3c61f |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Anticoagulation in Patients with Liver Cirrhosis (Literature Review)
by: E. S. Eniseeva
Published: (2019) -
The in vitro addition of idarucizumab to plasma samples from patients increases thrombin generation
by: Mojca Božič Mijovski, et al.
Published: (2021) -
Role of a thrombin generation assay in the prediction of infection severity
by: Boaz Elad, et al.
Published: (2021) -
Aggravation of fibrin deposition and microthrombus formation within the graft during kidney transplantation
by: Tamar A. J. van den Berg, et al.
Published: (2021) -
Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients
by: María Eugenia de la Morena-Barrio, et al.
Published: (2021)